120 related articles for article (PubMed ID: 12449017)
21. Role of endothelial nitric oxide synthase in the regulation of SREBP activation by oxidized phospholipids.
Gharavi NM; Baker NA; Mouillesseaux KP; Yeung W; Honda HM; Hsieh X; Yeh M; Smart EJ; Berliner JA
Circ Res; 2006 Mar; 98(6):768-76. PubMed ID: 16497987
[TBL] [Abstract][Full Text] [Related]
22. Pulsatile flow regulates monocyte adhesion to oxidized lipid-induced endothelial cells.
Hsiai TK; Cho SK; Reddy S; Hama S; Navab M; Demer LL; Honda HM; Ho CM
Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1770-6. PubMed ID: 11701464
[TBL] [Abstract][Full Text] [Related]
23. Structural identification of a novel pro-inflammatory epoxyisoprostane phospholipid in mildly oxidized low density lipoprotein.
Watson AD; Subbanagounder G; Welsbie DS; Faull KF; Navab M; Jung ME; Fogelman AM; Berliner JA
J Biol Chem; 1999 Aug; 274(35):24787-98. PubMed ID: 10455151
[TBL] [Abstract][Full Text] [Related]
24. Lovastatin inhibits oxidized L-A-phosphatidylcholine B-arachidonoyl-gamma-palmitoyl (ox-PAPC)-stimulated interleukin-8 mRNA and protein synthesis in human aortic endothelial cells by depleting stores of geranylgeranyl pyrophosphate.
Dvoracek LA; Kreisberg JI; McKinney J; Schmid G; Francis AD; Kacmarik KL; Lee HM; Detrick MS; Primerano DA; Santanam N; Kreisberg R
Atherosclerosis; 2010 Jan; 208(1):50-5. PubMed ID: 19595352
[TBL] [Abstract][Full Text] [Related]
25. Ox-PAPC activation of PMET system increases expression of heme oxygenase-1 in human aortic endothelial cell.
Lee S; Li R; Kim B; Palvolgyi R; Ho T; Yang QZ; Xu J; Szeto WL; Honda H; Berliner JA
J Lipid Res; 2009 Feb; 50(2):265-74. PubMed ID: 18757839
[TBL] [Abstract][Full Text] [Related]
26. Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position.
Subbanagounder G; Leitinger N; Schwenke DC; Wong JW; Lee H; Rizza C; Watson AD; Faull KF; Fogelman AM; Berliner JA
Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2248-54. PubMed ID: 11031211
[TBL] [Abstract][Full Text] [Related]
27. Modulation of endothelial cell proliferation and capillary network formation by the ox-LDL component: 1-palmitoyl-2-archidonoyl-sn-glycero-3-phosphocholine (ox-PAPC).
Kiec-Wilk B; Polus A; Razny U; Cialowicz U; Dembinska-Kiec A
Genes Nutr; 2011 Nov; 6(4):347-51. PubMed ID: 21484165
[TBL] [Abstract][Full Text] [Related]
28. Network for activation of human endothelial cells by oxidized phospholipids: a critical role of heme oxygenase 1.
Romanoski CE; Che N; Yin F; Mai N; Pouldar D; Civelek M; Pan C; Lee S; Vakili L; Yang WP; Kayne P; Mungrue IN; Araujo JA; Berliner JA; Lusis AJ
Circ Res; 2011 Aug; 109(5):e27-41. PubMed ID: 21737788
[TBL] [Abstract][Full Text] [Related]
29. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3.
Navab M; Hama SY; Anantharamaiah GM; Hassan K; Hough GP; Watson AD; Reddy ST; Sevanian A; Fonarow GC; Fogelman AM
J Lipid Res; 2000 Sep; 41(9):1495-508. PubMed ID: 10974057
[TBL] [Abstract][Full Text] [Related]
30. Epoxyisoprostane and epoxycyclopentenone phospholipids regulate monocyte chemotactic protein-1 and interleukin-8 synthesis. Formation of these oxidized phospholipids in response to interleukin-1beta.
Subbanagounder G; Wong JW; Lee H; Faull KF; Miller E; Witztum JL; Berliner JA
J Biol Chem; 2002 Mar; 277(9):7271-81. PubMed ID: 11751881
[TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor receptor 2 plays a role in the activation of aortic endothelial cells by oxidized phospholipids.
Zimman A; Mouillesseaux KP; Le T; Gharavi NM; Ryvkin A; Graeber TG; Chen TT; Watson AD; Berliner JA
Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):332-8. PubMed ID: 17110601
[TBL] [Abstract][Full Text] [Related]
32. Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells.
Khan BV; Parthasarathy SS; Alexander RW; Medford RM
J Clin Invest; 1995 Mar; 95(3):1262-70. PubMed ID: 7533787
[TBL] [Abstract][Full Text] [Related]
33. A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids.
Navab M; Hama SY; Hough GP; Subbanagounder G; Reddy ST; Fogelman AM
J Lipid Res; 2001 Aug; 42(8):1308-17. PubMed ID: 11483633
[TBL] [Abstract][Full Text] [Related]
34. Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids.
Leitinger N; Watson AD; Hama SY; Ivandic B; Qiao JH; Huber J; Faull KF; Grass DS; Navab M; Fogelman AM; de Beer FC; Lusis AJ; Berliner JA
Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1291-8. PubMed ID: 10323782
[TBL] [Abstract][Full Text] [Related]
35. Postprandial lipoproteins and the molecular regulation of vascular homeostasis.
Botham KM; Wheeler-Jones CP
Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609
[TBL] [Abstract][Full Text] [Related]
36. Monocyte binding to endothelial cells induced by oxidized phospholipids present in minimally oxidized low density lipoprotein is inhibited by a platelet activating factor receptor antagonist.
Leitinger N; Watson AD; Faull KF; Fogelman AM; Berliner JA
Adv Exp Med Biol; 1997; 433():379-82. PubMed ID: 9561175
[TBL] [Abstract][Full Text] [Related]
37. Potential role for mitogen-activated protein kinase phosphatase-1 in the development of atherosclerotic lesions in mouse models.
Reddy ST; Nguyen JT; Grijalva V; Hough G; Hama S; Navab M; Fogelman AM
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1676-81. PubMed ID: 15242861
[TBL] [Abstract][Full Text] [Related]
38. Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils.
Leitinger N; Tyner TR; Oslund L; Rizza C; Subbanagounder G; Lee H; Shih PT; Mackman N; Tigyi G; Territo MC; Berliner JA; Vora DK
Proc Natl Acad Sci U S A; 1999 Oct; 96(21):12010-5. PubMed ID: 10518567
[TBL] [Abstract][Full Text] [Related]
39. Determination of oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine products in human very low-density lipoproteins by nonaqueous low-flow capillary electrophoresis-mass spectrometry.
Chang CT; Chiu WC; Lin ZR; Shieh YT; Chang IT; Hsia MH; Wang CJ; Chen CJ; Liu MY
J Chromatogr A; 2023 Jan; 1687():463694. PubMed ID: 36502642
[TBL] [Abstract][Full Text] [Related]
40. Specific phospholipid oxidation products inhibit ligand activation of toll-like receptors 4 and 2.
Walton KA; Cole AL; Yeh M; Subbanagounder G; Krutzik SR; Modlin RL; Lucas RM; Nakai J; Smart EJ; Vora DK; Berliner JA
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1197-203. PubMed ID: 12775576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
